Response to primary chemotherapy in breast cancer patients with tumors not expressing estrogen and progesterone receptors (Q57580947)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038046%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Response to primary chemotherapy in breast cancer patients with tumors not expressing estrogen and progesterone receptors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038046%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038046%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Giuseppe Curigliano

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038046%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Paolo Veronesi

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038046%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

I Minchella

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038046%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

G Mazzarol

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038046%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

F Nolè

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038046%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

G Peruzzotti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038046%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A Rocca

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038046%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

G Viale

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038046%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

L Orlando

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038046%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

G Ferretti

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038046%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M Intra

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038046%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A Goldhirsch

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038046%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 August 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038046%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038046%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038046%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038046%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

1057-1059

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038046%20AND%20SRC:MED&resulttype=core&format=json

Primary chemotherapy in surgically resectable breast cancer

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008334404825

7 January 2021

Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008334404825

7 January 2021

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008334404825

7 January 2021

Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008334404825

7 January 2021

Clinical prognostic and predictive factors for primary chemotherapy in operable breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008334404825

7 January 2021

Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GST pi.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008334404825

7 January 2021

Prediction of response to primary chemotherapy for operable breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008334404825

7 January 2021

Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008334404825

7 January 2021

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008334404825

7 January 2021

Identifiers

DOI

10.1023/A:1008334404825

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038046%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference